Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome

J Clin Endocrinol Metab. 2024 Jul 11:dgae481. doi: 10.1210/clinem/dgae481. Online ahead of print.
No abstract available

Keywords: Polycystic ovary syndrome; cardiovascular disease; hormone-dependent cancers; metabolic dysfunction-associated steatotic liver disease; type 2 diabetes.